Lisa Kaminskas
Lisa Kaminskas
Associate Professor of Pharmacology and NHMRC Research Fellow, University of Queensland
Verified email at monash.edu
Title
Cited by
Cited by
Year
Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions
JR Gamble, J Drew, L Trezise, A Underwood, M Parsons, L Kasminkas, ...
Circulation research 87 (7), 603-607, 2000
5932000
From sewer to saviour—targeting the lymphatic system to promote drug exposure and activity
NL Trevaskis, LM Kaminskas, CJH Porter
Nature Reviews Drug Discovery 14 (11), 781-803, 2015
2212015
The Impact of Molecular Weight and PEG Chain Length on the Systemic Pharmacokinetics of PEGylated Poly l-Lysine Dendrimers
LM Kaminskas, BJ Boyd, P Karellas, GY Krippner, R Lessene, B Kelly, ...
Molecular pharmaceutics 5 (3), 449-463, 2008
1652008
Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties
LM Kaminskas, BJ Boyd, CJH Porter
Nanomedicine 6 (6), 1063-1084, 2011
1362011
Pharmacokinetics and Tumor Disposition of PEGylated, Methotrexate Conjugated Poly-l-lysine Dendrimers
LM Kaminskas, BD Kelly, VM McLeod, BJ Boyd, GY Krippner, ED Williams, ...
Molecular pharmaceutics 6 (4), 1190-1204, 2009
1332009
Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats
BJ Boyd, LM Kaminskas, P Karellas, G Krippner, R Lessene, CJH Porter
Molecular pharmaceutics 3 (5), 614-627, 2006
1322006
A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems
LM Kaminskas, VM McLeod, BD Kelly, G Sberna, BJ Boyd, M Williamson, ...
Nanomedicine: Nanotechnology, Biology and Medicine 8 (1), 103-111, 2012
1312012
Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products
PC Burcham, LM Kaminskas, FR Fontaine, DR Petersen, SM Pyke
Toxicology 181, 229-236, 2002
1282002
Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation
LM Kaminskas, VM McLeod, CJH Porter, BJ Boyd
Molecular pharmaceutics 9 (3), 355-373, 2012
1252012
Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy
LM Kaminskas, VM McLeod, GM Ryan, BD Kelly, JM Haynes, ...
Journal of Controlled Release 183, 18-26, 2014
1182014
PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats
LM Kaminskas, J Kota, VM McLeod, BD Kelly, P Karellas, CJH Porter
Journal of Controlled Release 140 (2), 108-116, 2009
1122009
New developments in dry powder pulmonary vaccine delivery
T Sou, EN Meeusen, M de Veer, DAV Morton, LM Kaminskas, ...
Trends in biotechnology 29 (4), 191-198, 2011
1102011
The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules
T Sou, LM Kaminskas, TH Nguyen, R Carlberg, MP McIntosh, DAV Morton
European Journal of Pharmaceutics and Biopharmaceutics 83 (2), 234-243, 2013
992013
Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker
LM Kaminskas, BD Kelly, VM McLeod, G Sberna, DJ Owen, BJ Boyd, ...
Journal of controlled release 152 (2), 241-248, 2011
982011
Targeting the lymphatics using dendritic polymers (dendrimers)
LM Kaminskas, CJH Porter
Advanced drug delivery reviews 63 (10-11), 890-900, 2011
912011
Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in mice
LM Kaminskas, SM Pyke, PC Burcham
Journal of Pharmacology and Experimental Therapeutics 310 (3), 1003-1010, 2004
882004
Pulmonary administration of PEGylated polylysine dendrimers: absorption from the lung versus retention within the lung is highly size-dependent
GM Ryan, LM Kaminskas, BD Kelly, DJ Owen, MP McIntosh, CJH Porter
Molecular pharmaceutics 10 (8), 2986-2995, 2013
762013
Protein adduct-trapping by hydrazinophthalazine drugs: mechanisms of cytoprotection against acrolein-mediated toxicity
PC Burcham, FR Fontaine, LM Kaminskas, DR Petersen, SM Pyke
Molecular pharmacology 65 (3), 655-664, 2004
692004
Doxorubicin-conjugated PEGylated dendrimers show similar tumoricidal activity but lower systemic toxicity when compared to PEGylated liposome and solution formulations in mouse …
LM Kaminskas, VM McLeod, BD Kelly, C Cullinane, G Sberna, ...
Molecular pharmaceutics 9 (3), 422-432, 2012
662012
Capping methotrexate α-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated PEGylated polylysine dendrimers
LM Kaminskas, BD Kelly, VM McLeod, G Sberna, BJ Boyd, DJ Owen, ...
Molecular pharmaceutics 8 (2), 338-349, 2011
592011
The system can't perform the operation now. Try again later.
Articles 1–20